Quick Takeaways: Why It Matters? By terminating the PrecisePRP arrangement with VetStem, PetVivo removes outstanding invoices, royalties and milestone overhangs from a non-core product line, which should simplify the story for investors and management while freeing attention and capital fo...
Quick Takeaways: Why It Matters? LIMPID’s acquisition of PetPeotalk turns Kinfora into a richer, behaviour‑driven pet health platform, because it brings in a mature vision‑AI stack (Dogibogi) with real‑world scale, hundreds of millions of labelled behaviour ...
Quick Takeaways: Why It Matters? Full FDA approval for Laverdia transforms it from a conditionally approved option into the first fully approved oral, at‑home standard therapy for canine lymphoma, which should significantly boost veterinarian confidence and utilization via Dechra’s nationa...
Quick Takeaways: Why It Matters? Elanco Ventures adds a structured, early-stage venture arm to Elanco’s strategy, giving the company a dedicated channel to access and co-develop emerging animal health technologies before they become mature competitors or acquisition targets. The ...
Quick Takeaways: Why It Matters? Pawsible Ventures is positioning itself as the “infrastructure VC” for pet health, and this eight‑company debut cohort shows what that means in practice: e‑prescribing rails (VetHubRx), AI clinic copilots (NxVET, PupPilot), preventive‑...
Quick Takeaways: Why It Matters? The $100M Symbiotic Capital facility, with $30M already drawn, gives TARGAN flexible, non‑dilutive growth capital, resets its lender base, and underwrites faster global deployment of WingScan at a time when revenues are already more th...
Quick Takeaways Why It Matters? The merger creates one of the most integrated players in animal health, combining physical distribution, practice software, and pharmacy services into a single, tech-enabled platform that can embed itself deeply in veterinary workflows. Vet...
